Lakefront Biotherapeutic...【LKFT】銘柄情報

Lakefront Biotherapeutics NV (LKFT) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

30.39

( 2.67% )

買値

23.33

売値

37.75

出来高

159,244

29.88 日の範囲 30.48

26.42 52 週間の範囲 30.41

時価総額

2.003B

前日終値

29.60

始値

30.11

時刻

30.5

最終取引時間

財務取引量

US$ 4,821,889

VWAP

30.2799

平均取引量 (3 か月)

US$ 73,182

発行済株式数

65,897,071

配当利回り

PER

3.51

1 株当たり利益 (EPS)

7.42

歳入

1.04B

純利益

488.78M

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG51... Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium. 詳細を表示

セクター

業界

ウェブサイト

lakefrontbio.com

本社

Mechelen, Belgium

設立

1999

Lakefront Biotherapeutics NV is listed in the sector of the ナスダック市場 with ticker LKFT. The last closing price for Lakefront Biotherapeutic... was US$29.60. Over the last year, Lakefront Biotherapeutic... shares have traded in a share price range of US$ 26.42 to US$ 30.41.

Lakefront Biotherapeutic... currently has 65,897,071 shares in issue. The market capitalisation of Lakefront Biotherapeutic... is US$2 billion. Lakefront Biotherapeutic... has a price to earnings ratio (PE ratio) of 3.51.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.39	4.79310344828	29	30.41	28.69	165011	29.56443962	DR
4	2.89	10.5090909091	27.5	30.41	27.5	177551	28.75954458	DR
12	2.39	8.53571428571	28	30.41	26.42	181930	28.15154764	DR
26	2.39	8.53571428571	28	30.41	26.42	181930	28.15154764	DR
52	2.39	8.53571428571	28	30.41	26.42	181930	28.15154764	DR
156	2.39	8.53571428571	28	30.41	26.42	181930	28.15154764	DR
260	2.39	8.53571428571	28	30.41	26.42	181930	28.15154764	DR